4Murray C, Lopez A. The global burden of disease[ M]. Cambridge: Harvard University Press, 1996.
5Yue XN, Liu ZF, Ye LX, et al. Research progress of the therapy in treatment-resistant depression [ J ]. Chin J Behav Med Brain Sci, 2016,25(3) : 280-284.DOI: lO.3760/cma.j.issn. 1674-6554.2016. 03.019.
6Wang YF, Du QR, Zhao JX, et al. Cognitive function impairment of patients with treatment-resistant depression and its clinical treat- ments[J]. Chin J Behav Med Brain Sci,2014,23(7) :594-597. DOI: 10.3760/cma.j. issn. 1674-6554.2014.07.006.
7Ohayon MM, Schatzherg AF. Prevalence of depressive episodes with psychotic features in the general population[ J]. Am J Psychi- atry,2002,159( 11 ) : 1855-1861. DOI: lO.1176/appi.ajp.159.11. 1855.
8Gaudiano BA, Beevers CG, Miller IW. Differential response to com- bined treatment in patients with psychotic versus nonpsychotic ma- jor depression[ J]. J Nervous Mental Dis,2005,193(9) :625-628.
9Buoli M,Caldiroli A, Altamura AC. Psychotic versus non-psychotic major depressive disorder: a comparative naturalistic study [ J ]. A- sian J Psychiatr, 2013,6 ( 4 ) : 333-337. DOI : 10.1016/j. ajp. 2013. 02.003.
10Rothschild AJ. Challenges in the treatment of depression with psy- chotic features [ J ]. Biological Psychiatry, 2003,53 (8) : 680-690.
